The peptide pheromone-inducible conjugation system of Enterococcus faecalis plasmid pCF10 Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Microbes
Microbes
Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was reviewed?
This review examined the peptide pheromone-inducible conjugation system of the Enterococcus faecalis plasmid pCF10, which controls antibiotic resistance transfer, virulence, and microbiome adaptation. The authors explained how donor bacteria detect peptide pheromones from nearby recipient bacteria and activate conjugation genes. This system regulates aggregation, DNA transfer, and virulence factor expression through plasmid-encoded sensing, quorum signaling, and regulatory mechanisms that respond to microbiome and host environmental signals.
Who was reviewed?
The review evaluated microbiome and clinical strains of Enterococcus faecalis carrying conjugative plasmid pCF10, including donor cells with plasmids and recipient cells lacking plasmids. These bacteria exist in the human gut microbiome and infection sites such as blood and tissues. The review examined bacterial populations involved in microbiome colonization, plasmid transfer, virulence activation, and antibiotic resistance dissemination.
What were the most important findings?
The pCF10 system enabled Enterococcus faecalis to detect microbiome density and transfer antibiotic resistance genes through pheromone signaling. Major microbial associations included increased abundance and virulence of plasmid-carrying Enterococcus strains, enhanced gene transfer, and increased aggregation and microbiome persistence. Recipient bacteria produced pheromone cCF10, which activated donor bacteria to express conjugation machinery, aggregation proteins, and DNA transfer systems. Donor bacteria also produced inhibitor peptide iCF10, which prevented unnecessary activation and allowed precise microbiome sensing. The ratio of pheromone to inhibitor determined activation, allowing Enterococcus to detect nearby recipient bacteria and selectively transfer plasmids. Conjugation genes encoded aggregation substance Asc10, which enhanced bacterial attachment, microbiome persistence, and virulence. Host bloodstream conditions reduced inhibitor activity, increasing pheromone signaling and virulence factor expression. These mechanisms promoted horizontal gene transfer, antibiotic resistance spread, microbiome dominance, and infection risk.
What are the greatest implications of this review?
This review showed that pheromone signaling allows Enterococcus to dynamically alter microbiome structure, increase virulence, and spread antibiotic resistance. Increased Enterococcus abundance, aggregation, and plasmid transfer represent important microbiome signatures of infection risk. These mechanisms explain how microbiome disruption enables Enterococcus expansion, virulence activation, and systemic infection.
Enterococcus faecalis
Enterococcus faecalis is a gut‑adapted, Gram‑positive, non‑spore‑forming facultative anaerobe that becomes an important opportunistic pathogen in healthcare when host barriers are breached or antibiotics select for enterococcal overgrowth. Its clinical impact is driven more by persistence, adhesion, and biofilm biology, quorum‑regulated secreted effectors (fsr‑controlled gelatinase GelE), and high genome plasticity than by a broad repertoire of classical tissue‑destroying toxins. Antimicrobial decision‑making must account for the intrinsic poor activity of cephalosporins, the potential for transferable glycopeptide resistance mediated by van gene clusters, and the need for regimen selection in endocarditis that respects synergy/tolerance and local high‑level aminoglycoside resistance patterns.